Ride the Pharma Wave with Our Rights Issue!

Share via:


Mumbai (Maharashtra) [India], April 28: Remedium Lifecare Limited (BSE: 539561) has announced the launch of its much-anticipated Rights Issue, which has received approval from the Bombay Stock Exchange (BSE). This strategic initiative marks a significant step in the company’s journey toward becoming a vertically integrated, research-driven pharmaceutical leader. The Rights Issue will open on April 30, 2025, and close on May 14, 2025.

The capital raise comes on the heels of Remedium’s recent ₹182.7 crore agreement with a prominent UK-based…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Popular

More Like this

Ride the Pharma Wave with Our Rights Issue!


Mumbai (Maharashtra) [India], April 28: Remedium Lifecare Limited (BSE: 539561) has announced the launch of its much-anticipated Rights Issue, which has received approval from the Bombay Stock Exchange (BSE). This strategic initiative marks a significant step in the company’s journey toward becoming a vertically integrated, research-driven pharmaceutical leader. The Rights Issue will open on April 30, 2025, and close on May 14, 2025.

The capital raise comes on the heels of Remedium’s recent ₹182.7 crore agreement with a prominent UK-based…



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.

Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi

More like this

Pine Labs Converts Into Public Entity In Run-Up To...

SUMMARY The fintech unicorn received shareholders’ nod on May...

Apple rolling out new software update for AirPods Max

Apple is rolling out a new firmware version...

Xiaomi to continue using Snapdragon 8-series in 15-year deal...

Qualcomm Technologies and Xiaomi have announced a multi-year...

Popular

Upcoming Events

Explainer: Why Jensen Huang’s latest Nvidia play will reverberate...

Nvidia selling its chip-to-chip communication tech should help...

Gulf deal-making spree also benefited Elon Musk and his...

President Donald Trump's recent trip to the Persian...

Apple Watch Series 10, iPad mini 7, Home Key...

Today’s best deals are kicking off with the...
dsa